These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24374862)

  • 21. Use of Wilms Tumor 1 Gene Expression as a Reliable Marker for Prognosis and Minimal Residual Disease Monitoring in Acute Myeloid Leukemia With Normal Karyotype Patients.
    Marjanovic I; Karan-Djurasevic T; Ugrin M; Virijevic M; Vidovic A; Tomin D; Suvajdzic Vukovic N; Pavlovic S; Tosic N
    Clin Lymphoma Myeloma Leuk; 2017 May; 17(5):312-319. PubMed ID: 28163010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Follow-up of minimal residual disease in acute childhood lymphoblastic leukemia by WT1 gene expression in the peripheral blood: the Hungarian experience.
    Magyarosy E; Varga N; Timár J; Rásó E
    Pediatr Hematol Oncol; 2003; 20(1):65-74. PubMed ID: 12687755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative assessment of Wilms tumor 1 (WT1) gene transcripts in Egyptian acute lymphoblastic leukemia patients.
    Sadek HA; El-Metnawey WH; Shaheen IA; Korshied MM; Mohamed AS
    J Investig Med; 2011 Dec; 59(8):1258-62. PubMed ID: 21804407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction in WT1 gene expression during early treatment predicts the outcome in patients with acute myeloid leukemia.
    Andersson C; Li X; Lorenz F; Golovleva I; Wahlin A; Li A
    Diagn Mol Pathol; 2012 Dec; 21(4):225-33. PubMed ID: 23111196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of quantitative analysis of WT1 gene transcripts in adult acute lymphoblastic leukemia.
    Chiusa L; Francia di Celle P; Campisi P; Ceretto C; Marmont F; Pich A
    Haematologica; 2006 Feb; 91(2):270-1. PubMed ID: 16461320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wilms' tumor gene 1 transcript levels in leukapheresis of peripheral blood hematopoietic cells predict relapse risk in patients autografted for acute myeloid leukemia.
    Messina C; Candoni A; Carrabba MG; Tresoldi C; Sala E; Tassara M; Crippa A; Peccatori J; Assanelli A; Gattillo S; Bellio L; Fanin R; Ciceri F; Bernardi M
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1586-91. PubMed ID: 24954546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic implications of mutations and expression of the Wilms tumor 1 (WT1) gene in adult acute T-lymphoblastic leukemia.
    Heesch S; Goekbuget N; Stroux A; Tanchez JO; Schlee C; Burmeister T; Schwartz S; Blau O; Keilholz U; Busse A; Hoelzer D; Thiel E; Hofmann WK; Baldus CD
    Haematologica; 2010 Jun; 95(6):942-9. PubMed ID: 20435628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic potential of detection of WT1 mRNA level in peripheral blood in adult acute myeloid leukemia.
    Miyawaki S; Hatsumi N; Tamaki T; Naoe T; Ozawa K; Kitamura K; Karasuno T; Mitani K; Kodera Y; Yamagami T; Koga D
    Leuk Lymphoma; 2010 Oct; 51(10):1855-61. PubMed ID: 20849384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Involvement of WT1 gene expression in regulation of P53 and MDM2 proteins function in acute lymphoblastic leukemia].
    Bartkowiak J; Wójcik I; Stankiewicz W
    Pol Merkur Lekarski; 2001 Nov; 11(65):402-5. PubMed ID: 11852808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of Wilms tumor gene (WT1) in children with acute leukemia.
    Im HJ; Kong G; Lee H
    Pediatr Hematol Oncol; 1999; 16(2):109-18. PubMed ID: 10100271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Fluorescence quantitative PCR detection of WT1 gene expression in peripheral blood of patients with acute leukemias and its clinical implications].
    Bai B; Wang HW; Xu YQ; Yang HN; Qiao ZH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):610-4. PubMed ID: 16129044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wilms' tumor gene (WT1) expression correlates with vascular epithelial growth factor (VEGF) in newly acute leukemia patients undergoing chemotherapy.
    Iranparast S; Assarehzadegan MA; Heike Y; Hossienzadeh M; Khodadadi A
    Asian Pac J Cancer Prev; 2014; 15(21):9217-23. PubMed ID: 25422204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias.
    Menssen HD; Renkl HJ; Rodeck U; Maurer J; Notter M; Schwartz S; Reinhardt R; Thiel E
    Leukemia; 1995 Jun; 9(6):1060-7. PubMed ID: 7596170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of Wilms tumor 1 gene as a negative prognostic indicator in acute myeloid leukemia.
    Lyu X; Xin Y; Mi R; Ding J; Wang X; Hu J; Fan R; Wei X; Song Y; Zhao RY
    PLoS One; 2014; 9(3):e92470. PubMed ID: 24667279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. WT1 expression at diagnosis does not predict survival in pediatric AML: a report from the Children's Oncology Group.
    Noronha SA; Farrar JE; Alonzo TA; Gerbing RB; Lacayo NJ; Dahl GV; Ravindranath Y; Arceci RJ; Loeb DM
    Pediatr Blood Cancer; 2009 Dec; 53(6):1136-9. PubMed ID: 19618455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic implications of Wilms' tumor gene (WT1) expression in patients with de novo acute myeloid leukemia.
    Barragán E; Cervera J; Bolufer P; Ballester S; Martín G; Fernández P; Collado R; Sayas MJ; Sanz MA
    Haematologica; 2004 Aug; 89(8):926-33. PubMed ID: 15339675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical significance of the alternative Wilms tumor gene overexpression-hypermethylation signature in acute myeloid leukemia.
    El Bordiny M; Al-Ghandour A; Abo Elwafa RA; Fayed O
    Clin Transl Oncol; 2019 Jul; 21(7):864-873. PubMed ID: 30506133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. WT1 mRNA in cerebrospinal fluid associated with relapse in pediatric lymphoblastic leukemia.
    Ramirez O; Linares A; Trujillo ML; Caminos JE
    J Pediatr Hematol Oncol; 2003 Jun; 25(6):453-8. PubMed ID: 12794523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients.
    Cilloni D; Gottardi E; De Micheli D; Serra A; Volpe G; Messa F; Rege-Cambrin G; Guerrasio A; Divona M; Lo Coco F; Saglio G
    Leukemia; 2002 Oct; 16(10):2115-21. PubMed ID: 12357365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Proportional Relationship Between Pretransplant WT1 mRNA Levels and Risk of Mortality After Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Not in Remission.
    Ido K; Nakamae M; Koh H; Okamura H; Nanno S; Nishimoto M; Takeoka Y; Hirose A; Nakashima Y; Hashimoto Y; Nakane T; Hino M; Nakamae H
    Transplantation; 2019 Oct; 103(10):2201-2210. PubMed ID: 30801534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.